The Potential for Cell-Based Therapy in Perinatal Brain Injuries

Translational Stroke Research

Volumn 4, Issue 2, 2013, Pages 137-148

  Phillips, Andre W ^a,b   Johnston, Michael V ^a,b   Fatemi, Ali ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain injury; Cerebral palsy; Hypoxia ischemia; Neonate; Stem cell

Indexed keywords

ACUTE BRAIN DISEASE; ADIPOCYTE; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOTRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN ATROPHY; BRAIN INJURY; BRAIN ISCHEMIA; CARCINOGENICITY; CELL FUSION; CEREBRAL PALSY; CHROMOSOME ABERRATION; CLINICAL TRIAL (TOPIC); CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FIBROBLAST; GESTATIONAL AGE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HYDROCEPHALUS; INFANTILE SPASM; INFLAMMATION; INTELLIGENCE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; MYELIN DEFICIENCY; MYELINATION; NEUROIMAGING; NEWBORN DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY EPITHELIUM; OLIGODENDROGLIA; OSTEOBLAST; PATHOPHYSIOLOGY; PERINATAL BRAIN INJURY; PERINATAL PERIOD; PLURIPOTENT STEM CELL; PREMATURITY; PRIORITY JOURNAL; QUADRIPLEGIA; REVIEW; STEM CELL NICHE; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD CELL TRANSPLANTATION; WHITE MATTER; WHITE MATTER INJURY;

BRAIN INJURY; CEREBRAL PALSY; HYPOXIA ISCHEMIA; NEONATE; STEM CELL;

ANIMALS; BRAIN INJURIES; CEREBRAL PALSY; FETAL HYPOXIA; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; STEM CELL TRANSPLANTATION;

EID: 84875051598     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-013-0254-5     Document Type: Review

References (93)

1. Berger R, Garnier Y, Jensen A. Perinatal brain damage: underlying mechanisms and neuroprotective strategies. J Soc Gynecol Investig. 2002; 9(6): 319-28.
2. Johnston MV, Hoon Jr AH. Cerebral palsy. Neuromol Med. 2006; 8(4): 435-50.
3. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res. 2001; 50(5): 553-62.
4. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007; 109: 8-14.
5. Barkovich AJ, Hajnal BL, Vigneron D, Sola A, Partridge JC, Allen F, et al. Prediction of neuromotor outcome in perinatal asphyxia: evaluation of MR scoring systems. AJNR Am J Neuroradiol. 1998; 19(1): 143-9.
6. Bartha AI, Foster-Barber A, Miller SP, Vigneron DB, Glidden DV, Barkovich AJ, et al. Neonatal encephalopathy: association of cytokines with MR spectroscopy and outcome. Pediatr Res. 2004; 56(6): 960-6. doi: 10. 1203/01. PDR. 0000144819. 45689. BB.
7. Falini A, Barkovich AJ, Calabrese G, Origgi D, Triulzi F, Scotti G. Progressive brain failure after diffuse hypoxic ischemic brain injury: a serial MR and proton MR spectroscopic study. AJNR Am J Neuroradiol. 1998; 19(4): 648-52.
8. Ramaswamy V, Miller SP, Barkovich AJ, Partridge JC, Ferriero DM. Perinatal stroke in term infants with neonatal encephalopathy. Neurology. 2004; 62(11): 2088-91.
9. Barkovich AJ, Sargent SK. Profound asphyxia in the premature infant: Imaging findings. AJNR Am J Neuroradiol. 1995; 16(9): 1837-46.
10. Johnston MV. Excitotoxicity in perinatal brain injury. Brain Pathol (Zurich, Switzerland). 2005; 15(3): 234-40.
11. Northington FJ, Ferriero DM, Flock DL, Martin LJ. Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci Off J Soc Neurosci. 2001; 21(6): 1931-8.
12. Northington FJ, Ferriero DM, Graham EM, Traystman RJ, Martin LJ. Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis. Neurobiol Dis. 2001; 8(2): 207-19. doi: 10. 1006/nbdi. 2000. 0371.
13. Northington FJ, Ferriero DM, Martin LJ. Neurodegeneration in the thalamus following neonatal hypoxia-ischemia is programmed cell death. Dev Neurosci. 2001; 23(3): 186-91.
14. Hoon Jr AH, Freese PO, Reinhardt EM, Wilson MA, Lawrie Jr WT, Harryman SE, et al. Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy. Pediatr Neurol. 2001; 25(1): 55-8.
15. Blumenthal I. Periventricular leucomalacia: a review. Eur J Pediatr. 2004; 163(8): 435-42. doi: 10. 1007/s00431-004-1477-y.
16. Khwaja O, Volpe JJ. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed. 2008; 93(2): F153-61. doi: 10. 1136/adc. 2006. 108837.
17. Leviton A, Gilles F. Ventriculomegaly, delayed myelination, white matter hypoplasia, and "periventricular" leukomalacia: how are they related? Pediatr Neurol. 1996; 15(2): 127-36.
18. Webber DJ, van Blitterswijk M, Chandran S. Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia. Am J Pathol. 2009; 175(6): 2332-42. doi: 10. 2353/ajpath. 2009. 090051.
19. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA. 1997; 278(3): 207-11.
20. Leviton A, Gressens P. Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci. 2007; 30(9): 473-8. doi: 10. 1016/j. tins. 2007. 05. 009.
21. Bloch JR. Antenatal events causing neonatal brain injury in premature infants. J Obstet Gynecol Neonatal Nurs. 2005; 34(3): 358-66. doi: 10. 1177/0884217505276255.
22. Mitalipov S, Wolf D. Totipotency, pluripotency and nuclear reprogramming. Adv Biochem Eng Biotechnol. 2009; 114: 185-99. doi: 10. 1007/10_2008_45.
23. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292(5819): 154-6.
24. Leeb C, Jurga M, McGuckin C, Forraz N, Thallinger C, Moriggl R, et al. New perspectives in stem cell research: beyond embryonic stem cells. Cell Prolif. 2011; 44 Suppl 1: 9-14. doi: 10. 1111/j. 1365-2184. 2010. 00725. x.
25. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981; 78(12): 7634-8.
26. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science (New York, NY). 1998; 282(5391): 1145-7.
27. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4): 663-76. doi: 10. 1016/j. cell. 2006. 07. 024.
28. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5): 861-72. doi: 10. 1016/j. cell. 2007. 11. 019.
29. Pluchino S, Zanotti L, Brini E, Ferrari S, Martino G. Regeneration and repair in multiple sclerosis: The role of cell transplantation. Neurosci Lett. 2009; 456(3): 101-6. doi: 10. 1016/j. neulet. 2008. 03. 097.
30. Luskin MB, Pearlman AL, Sanes JR. Cell lineage in the cerebral cortex of the mouse studied in vivo and in vitro with a recombinant retrovirus. Neuron. 1988; 1(8): 635-47.
31. Turner DL, Cepko CL. A common progenitor for neurons and glia persists in rat retina late in development. Nature. 1987; 328(6126): 131-6. doi: 10. 1038/328131a0.
32. Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO, Wall DA. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant. 2001; 7(11): 581-8.
33. Wurmser AE, Nakashima K, Summers RG, Toni N, D'Amour KA, Lie DC, et al. Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature. 2004; 430(6997): 350-6. doi: 10. 1038/nature02604.
34. Condorelli G, Borello U, De Angelis L, Latronico M, Sirabella D, Coletta M, et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration. Proc Natl Acad Sci U S A. 2001; 98(19): 10733-8. doi: 10. 1073/pnas. 191217898.
35. Galli R, Borello U, Gritti A, Minasi MG, Bjornson C, Coletta M, et al. Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci. 2000; 3(10): 986-91. doi: 10. 1038/79924.
36. Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A. 2003; 100 Suppl 1: 11917-23. doi: 10. 1073/pnas. 1834138100.
37. Spees JL, Olson SD, Ylostalo J, Lynch PJ, Smith J, Perry A, et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci U S A. 2003; 100(5): 2397-402. doi: 10. 1073/pnas. 0437997100.
38. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature. 2002; 416(6880): 545-8. doi: 10. 1038/nature729.
39. Park KI, Teng YD, Snyder EY. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol. 2002; 20(11): 1111-7. doi: 10. 1038/nbt751.
40. Schwartz PH, Bryant PJ, Fuja TJ, Su H, O'Dowd DK, Klassen H. Isolation and characterization of neural progenitor cells from post-mortem human cortex. J Neurosci Res. 2003; 74(6): 838-51. doi: 10. 1002/jnr. 10854.
41. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol. 2003; 54(3): 403-14. doi: 10. 1002/ana. 10720.
42. Flomenberg N, Devine SM, Dipersio JF, Liesveld JL, McCarty JM, Rowley SD, et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood. 2005; 106(5): 1867-74. doi: 10. 1182/blood-2005-02-0468.
43. McCulloch EA, Till JE. The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice. Radiat Res. 1960; 13: 115-25.
44. da Silva ML, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006; 119(Pt 11): 2204-13. doi: 10. 1242/jcs. 02932.
45. Paul G, Ozen I, Christophersen NS, Reinbothe T, Bengzon J, Visse E, et al. The adult human brain harbors multipotent perivascular mesenchymal stem cells. PLoS One. 2012; 7(4): e35577. doi: 10. 1371/journal. pone. 0035577.
46. Phillips AW, Falahati S, Desilva R, Shats I, Marx J, Arauz E, et al. Derivation of glial restricted precursors from E13 mice. J Vis Exp. 2012; 64. doi: 10. 3791/3462.
47. Rao MS, Mayer-Proschel M. Glial-restricted precursors are derived from multipotent neuroepithelial stem cells. Dev Biol. 1997; 188(1): 48-63. doi: 10. 1006/dbio. 1997. 8597.
48. Walczak P, All AH, Rumpal N, Gorelik M, Kim H, Maybhate A, et al. Human glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination. Glia. 2011; 59(3): 499-510. doi: 10. 1002/glia. 21119.
49. Goldman SA, Nedergaard M, Windrem MS. Glial progenitor cell-based treatment and modeling of neurological disease. Science (New York, NY). 2012; 338(6106): 491-5.
50. Barnett SC, Hutchins AM, Noble M. Purification of olfactory nerve ensheathing cells from the olfactory bulb. Dev Biol. 1993; 155(2): 337-50. doi: 10. 1006/dbio. 1993. 1033.
51. Shyu WC, Liu DD, Lin SZ, Li WW, Su CY, Chang YC, et al. Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke. J Clin Invest. 2008; 118(7): 2482-95. doi: 10. 1172/JCI34363.
52. Barnett SC, Chang L. Olfactory ensheathing cells and CNS repair: going solo or in need of a friend? Trends Neurosci. 2004; 27(1): 54-60. doi: 10. 1016/j. tins. 2003. 10. 011.
53. Woodhall E, West AK, Chuah MI. Cultured olfactory ensheathing cells express nerve growth factor, brain-derived neurotrophic factor, glia cell line-derived neurotrophic factor and their receptors. Brain Res Mol Brain Res. 2001; 88(1-2): 203-13.
54. Comi AM, Cho E, Mulholland JD, Hooper A, Li Q, Qu Y, et al. Neural stem cells reduce brain injury after unilateral carotid ligation. Pediatr Neurol. 2008; 38(2): 86-92. doi: 10. 1016/j. pediatrneurol. 2007. 10. 007.
55. Tarasenko YI, Gao J, Nie L, Johnson KM, Grady JJ, Hulsebosch CE, et al. Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. J Neurosci Res. 2007; 85(1): 47-57. doi: 10. 1002/jnr. 21098.
56. Elsayed MH, Hogan TP, Shaw PL, Castro AJ. Use of fetal cortical grafts in hypoxic-ischemic brain injury in neonatal rats. Exp Neurol. 1996; 137(1): 127-41. doi: 10. 1006/exnr. 1996. 0013.
57. Bjorklund A, Stenevi U, Schmidt RH, Dunnett SB, Gage FH. Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta Physiol Scand Suppl. 1983; 522: 1-7.
58. Bjorklund A, Gage FH, Schmidt RH, Stenevi U, Dunnett SB. Intracerebral grafting of neuronal cell suspensions. VII. Recovery of choline acetyltransferase activity and acetylcholine synthesis in the denervated hippocampus reinnervated by septal suspension implants. Acta Physiol Scand Suppl. 1983; 522: 59-66.
59. Bjorklund A, Stenevi U, Schmidt RH, Dunnett SB, Gage FH. Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different brain sites. Acta Physiol Scand Suppl. 1983; 522: 9-18.
60. Gage FH, Bjorklund A, Stenevi U, Dunnett SB. Intracerebral grafting of neuronal cell suspensions. VIII. Survival and growth of implants of nigral and septal cell suspensions in intact brains of aged rats. Acta Physiol Scand Suppl. 1983; 522: 67-75.
61. Grabowski M, Brundin P, Johansson BB. Fetal neocortical grafts implanted in adult hypertensive rats with cortical infarcts following a middle cerebral artery occlusion: ingrowth of afferent fibers from the host brain. Exp Neurol. 1992; 116(2): 105-21.
62. Jansen EM, Solberg L, Underhill S, Wilson S, Cozzari C, Hartman BK, et al. Transplantation of fetal neocortex ameliorates sensorimotor and locomotor deficits following neonatal ischemic-hypoxic brain injury in rats. Exp Neurol. 1997; 147(2): 487-97. doi: 10. 1006/exnr. 1997. 6596.
63. Roach A, Takahashi N, Pravtcheva D, Ruddle F, Hood L. Chromosomal mapping of mouse myelin basic protein gene and structure and transcription of the partially deleted gene in shiverer mutant mice. Cell. 1985; 42(1): 149-55.
64. Bird TD, Farrell DF, Sumi SM. Brain lipid composition of the shiverer mouse: (genetic defect in myelin development). J Neurochem. 1978; 31(1): 387-91.
65. Lachapelle F, Gumpel M, Baulac M, Jacque C, Duc P, Baumann N. Transplantation of CNS fragments into the brain of shiverer mutant mice: extensive myelination by implanted oligodendrocytes. I Immunohistochemical Stud Dev Neurosci. 1983; 6(6): 325-34.
66. Zhang SC, Ge B, Duncan ID. Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proc Natl Acad Sci U S A. 1999; 96(7): 4089-94.
67. Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA, McKhann 2nd G, et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nature Med. 2004; 10(1): 93-7. doi: 10. 1038/nm974.
68. Windrem MS, Schanz SJ, Guo M, Tian GF, Washco V, Stanwood N, et al. Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell. 2008; 2(6): 553-65. doi: 10. 1016/j. stem. 2008. 03. 020.
69. Zheng T, Rossignol C, Leibovici A, Anderson KJ, Steindler DA, Weiss MD. Transplantation of multipotent astrocytic stem cells into a rat model of neonatal hypoxic-ischemic encephalopathy. Brain Res. 2006; 1112(1): 99-105. doi: 10. 1016/j. brainres. 2006. 07. 014.
70. Park KI, Hack MA, Ourednik J, Yandava B, Flax JD, Stieg PE, et al. Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells. Exp Neurol. 2006; 199(1): 156-78. doi: 10. 1016/j. expneurol. 2006. 04. 002.
71. Park KI, Himes BT, Stieg PE, Tessler A, Fischer I, Snyder EY. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp Neurol. 2006; 199(1): 179-90. doi: 10. 1016/j. expneurol. 2006. 03. 016.
72. Pimentel-Coelho PM, Magalhaes ES, Lopes LM, de Azevedo LC, Santiago MF, Mendez-Otero R. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev. 2010; 19(3): 351-8. doi: 10. 1089/scd. 2009. 0049.
73. Yasuhara T, Hara K, Maki M, Xu L, Yu G, Ali MM, et al. Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts. J Cell Mol Med. 2010; 14(4): 914-21. doi: 10. 1111/j. 1582-4934. 2008. 00671. x.
74. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4): 315-7. doi: 10. 1080/14653240600855905.
75. Gupta N, Henry RG, Strober J, Kang SM, Lim DA, Bucci M, et al. Neural stem cell engraftment and myelination in the human brain. Sci Transl Med. 2012; 4(155): 155ra37.
76. Meier C, Middelanis J, Wasielewski B, Neuhoff S, Roth-Haerer A, Gantert M, et al. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res. 2006; 59(2): 244-9. doi: 10. 1203/01. pdr. 0000197309. 08852. f5.
77. Prasad VK, Kurtzberg J. Umbilical cord blood transplantation for non-malignant diseases. Bone Marrow Transplant. 2009; 44(10): 643-51. doi: 10. 1038/bmt. 2009. 290.
78. Yang WZ, Zhang Y, Wu F, Min WP, Minev B, Zhang M, et al. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J Transl Med. 2010; 8: 75. doi: 10. 1186/1479-5876-8-75.
79. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood. 2003; 101(8): 2999-3001. doi: 10. 1182/blood-2002-06-1830.
80. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A. 1999; 96(19): 10711-6.
81. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006; 24(1): 74-85. doi: 10. 1634/stemcells. 2004-0359.
82. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun. 2010; 24(3): 387-93. doi: 10. 1016/j. bbi. 2009. 10. 017.
83. Fan CG, Zhang QJ, Tang FW, Han ZB, Wang GS, Han ZC. Human umbilical cord blood cells express neurotrophic factors. Neurosci Lett. 2005; 380(3): 322-5. doi: 10. 1016/j. neulet. 2005. 01. 070.
84. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009; 5(1): 54-63. doi: 10. 1016/j. stem. 2009. 05. 003.
85. Phinney DG, Hill K, Michelson C, DuTreil M, Hughes C, Humphries S, et al. Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental potential and broad therapeutic efficacy. Stem Cells. 2006; 24(1): 186-98. doi: 10. 1634/stemcells. 2004-0236.
86. Rosenkranz K, Meier C. Umbilical cord blood cell transplantation after brain ischemia-from recovery of function to cellular mechanisms. Ann Anat. 2011; 193(4): 371-9. doi: 10. 1016/j. aanat. 2011. 03. 005.
87. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A. 2004; 101(52): 18117-22. doi: 10. 1073/pnas. 0408258102.
88. Lee IS, Jung K, Kim M, Park KI. Neural stem cells: properties and therapeutic potentials for hypoxic-ischemic brain injury in newborn infants. Pediatr Int. 2010; 52(6): 855-65. doi: 10. 1111/j. 1442-200X. 2010. 03266. x.
89. Chen L, Huang H, Xi H, Xie Z, Liu R, Jiang Z, et al. Intracranial transplant of olfactory ensheathing cells in children and adolescents with cerebral palsy: a randomized controlled clinical trial. Cell Transplant. 2010; 19(2): 185-91. doi: 10. 3727/096368910X492652.
90. Shi X, Kang Y, Hu Q, Chen C, Yang L, Wang K, et al. A long-term observation of olfactory ensheathing cells transplantation to repair white matter and functional recovery in a focal ischemia model in rat. Brain Res. 2010; 1317: 257-67. doi: 10. 1016/j. brainres. 2009. 12. 061.
91. Liu Y, Jiang X, Zhang X, Chen R, Sun T, Fok KL, et al. Dedifferentiation-reprogrammed mesenchymal stem cells with improved therapeutic potential. Stem Cells. 2011; 29(12): 2077-89. doi: 10. 1002/stem. 764.
92. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatr Res. 2010; 68(5): 419-22. doi: 10. 1203/PDR. 0b013e3181f1c289.
93. Lee JA, Kim BI, Jo CH, Choi CW, Kim EK, Kim HS, et al. Mesenchymal stem-cell transplantation for hypoxic-ischemic brain injury in neonatal rat model. Pediatr Res. 2010; 67(1): 42-6. doi: 10. 1203/PDR. 0b013e3181bf594b.